Facts about Covishield Vaccine

Covishield is Covid-19 coronavirus vaccine by Serum institute and Astrazeneca approved by DCGI to for emergency use in India.

Covishield is Covid-19 coronavirus vaccine by Serum institute and Astrazeneca approved by DCGI to for emergency use in India.

Bi-Folate mouth ulcer gel

Bi-Folate mouth ulcer gel

Bi-folate mouth ulcer gel is used to apply locally on mouth ulcer to reduce pain and as mild antiseptic also contains glycerin to keep moist.

Imojev: Live attenuated Japanese Encephalitis Vaccine

Imojev is live attenuated virus vaccine given to prevent Japanses encephalitis disease above age 9 months and booster after 1 year of 1st dose

Imojev is live attenuated virus vaccine given to prevent Japanses encephalitis disease above age 9 months and booster after 1 year of 1st dose

BCG vaccine prevents severe tuberculosis disease

BCG vaccine prevents severe tuberculosis disease

BCG vaccine is given to infants and young children to prevent severe and complicated disease tuberculosis intradermally as indicated

Zostavax live attenuated vaccine for shingles

Zostavax live attenuated vaccine for shingles

Zostavax live attenuated vaccine for shingles is given for those above 50 years of age to prevent shingles subcutaneous as indicated

Stamaril: Live Yellow fever vaccine

Stamaril: Live Yellow fever vaccine

Stamaril is live attenuated Yellow fever vaccine is given to prevent Yellow fever disease in travelers those visiting endemic areas

MMR II vaccine: A live attenuated MMR vaccine

MMR II vaccine: A live attenuated MMR vaccine

MMR II is live attenuated vaccine used to prevent measles, mumps and rubella can be given at age 12-15 months and then 4 years as indicated

Flumist: Quadrivalent live attenuated influenza vaccine

Flumist: Quadrivalent live attenuated influenza vaccine

Flumist quadrivalent vaccine is live attenuated influenza shot given by sparying in nose one or two doses in those 2 to 49 years as indicated

Dengvaxia: live Tetravalent Dengue vaccine

Dengvaxia is live attenuated tetravalent Dengue virus vaccine is approved for age 9-16 years who test positive for dengue IgG antibody

Dengvaxia is live attenuated tetravalent Dengue virus vaccine is approved for age 9-16 years who test positive for dengue IgG antibody

MR-Vac live measles, rubella vaccine

MR-Vac live measles and rubella vaccine

MR-Vac is live vaccine given to prevent measles and rubella in children and adults as indicated given at age 9, 15 months and 5 years.

%d bloggers like this: